Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis

Hailian Lin, Kelang Wang, Kebing Zou, Yuanyuan Wang, Gen xiang Que, Xuefeng Yang, Mengdan Liao

Open source

DOI
10.1155/2022/7264503
Published
2022-08-09
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/7264503,
  title = {Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis},
  author = {Hailian Lin and Kelang Wang and Kebing Zou and Yuanyuan Wang and Gen xiang Que and Xuefeng Yang and Mengdan Liao},
  year = {2022},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2022/7264503},
  url = {https://doi.org/10.1155/2022/7264503}
}

RIS

TY  - JOUR
TI  - Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis
AU  - Hailian Lin
AU  - Kelang Wang
AU  - Kebing Zou
AU  - Yuanyuan Wang
AU  - Gen xiang Que
AU  - Xuefeng Yang
AU  - Mengdan Liao
PY  - 2022
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2022/7264503
UR  - https://doi.org/10.1155/2022/7264503
ER  - 

APA

Lin, H., Wang, K., Zou, K., Wang, Y., Que, G. X., Yang, X., & Liao, M. (2022). Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2022/7264503

Source records